Wednesday, November 29, 2023
No Result
View All Result
No Result
View All Result

Fresh Tracks Therapeutics (FRTX) Stock Forecast & Price Prediction

Estimation of the future price movement of Fresh Tracks Therapeutics stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $0.79

Concensus $0.00

Low $0.00

Median $0.00

High $0.00

Based on analysts projections #FRTX is expected to experience a price decline over the next year.

The current average FRTX price target, as estimated by these analysts, is $0.00.

The predictions for the future FRTX stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for FRTX.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

FRTX stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted

There are no data to display

Fresh Tracks Therapeutics (FRTX) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Fresh Tracks Therapeutics is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Neutral

Financial Scores

Updated on: 29/11/2023

Altman Z-Score: -17.5

Piotroski Score: 3.0

ESG Score

Updated on: 29/11/2023

Environmental: 62.3

Social: 74.0

Governance: 66.0

Financial Health

Updated on: 29/11/2023

DCF: Strong Buy

ROE: Strong Sell

ROA: Strong Sell

Debt to equity ratio: Neutral

Price to earnings ratio: Neutral

Price to book ratio: Buy

FRTX Discounted Cash Flow

Updated on: 29/11/2023

$0.000
Discounted Cash Flow Value

$0.000
Current Price

FRTX Revenues by Segment

Updated on: 29/11/2023

Consulting Services
$7,940.00

Revenue from Contract with Customer, Excluding Assessed Tax

FRTX Revenues by Region

Updated on: 29/11/2023

No available data

FRTX Notes Due

Updated on: 29/11/2023

CIKExchangeTitle

There are no data to display

Fresh Tracks Therapeutics (FRTX) Social Sentiments

Monitoring bullish and bearish sentiments towards Fresh Tracks Therapeutics on Twitter and Stocktwits could help to forecast an upward or downward trend in Fresh Tracks Therapeutics stock price.

Fresh Tracks Therapeutics Stock Forecast: Promising Innovations in Biotechnology Sector

Fresh Tracks Therapeutics (FRTX) is a promising player in the biotechnology sector. This relatively new company has made its presence felt as a publicly traded organization through some key strategies, such as their focus on developing innovative therapies and drugs for unmet medical conditions. With an impressive track record of success in securing substantial funding from venture capital firms, the... Read more

Predicting Biotech Success: A Look at Fresh Tracks Therapeutics' Stock Prediction

The biotechnology industry is a rapidly growing sector that focuses on the development and commercialization of life-saving drugs, vaccines, medical devices, and diagnostic tests. It is an essential field that has revolutionized healthcare by creating new and improved methods for treating various diseases. Investing in the biotechnology stock market can be highly profitable but also carries high risks due to... Read more
No Result
View All Result

© 2023 Best Stocks